FindTrial
Sign In

A STUDY ON KADUKKAI MATHIRAI IN THE MANAGEMENT OF URAKARI VATHAM (NON-ALCOHOLIC FATTY LIVER DISEASE)

SINGLE CENTRIC NON-RANDOMIZED OPEN CLINICAL TRIAL PHASE II IN URAKARI VATHAM (NON-ALCOHOLIC FATTY LIVER DISEASE) WITH SIDDHA MEDICINE KADUKKAI MATHIRAI AMONG PATIENTS ATTENDING OPD IN GOVERNMENT SIDDHA MEDICAL COLLEGE HOSPITAL - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086413
Enrollment
40
Registered
2025-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E713- Disorders of fatty-acid metabolism

Interventions

Intervention1: KADUKKAI MATHIRAI: 1 to 2 tablets, twice a day for 48 days, Control Intervention1: Nil: Nil

Sponsors

Government siddha medical College, chennai.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Sex- all genders Subjects with age between 30 to 65 years Patients with grade 1 - grade 2 fatty liver in USG abdomen, Patients with dyslipedimia, type 2 diabetes mellitus,

Exclusion criteria

Exclusion criteria: Pregnancy women Lactating mother Patients who are known to consume alcohol Patients with chronic kidney disease and cardiovascular disease Patients with liver disease such as viral hepatitis, autoimmune disorders,biliary disorders,liver abscess, cirrhosis and malignancy.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of kadukkai mathirai in Urakari vatham (NAFLD) by reduction in the grades of fatty liver in USG abdomenTimepoint: 48 days—

Secondary

MeasureTime frame
Reduction in values of lipid profile and LFT will be assessed before and after treatment Reduction in the symptoms of urakari vatham (NAFLD) before and after treatmentTimepoint: 48 days—

Countries

India

Contacts

Public ContactDr R MENAKA

Government siddha medical College, chennai

rangasamymenaka75@gmail.com9444669661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026